A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Digital supply networks: A new imperative for life sciences

by Stephen Laaper, Principal, and John Allen, Senior Manager, Deloitte Consulting LLP

Life sciences companies are usually not considered market leaders in the race to embrace new technology and digital transformation. Whether deserved or not, this reputation—and the reality—should change. Without the advantages of digital, leaders in life sciences could lose competitive ground that can’t easily be regained.

It’s an urgent call to action, but also a huge opportunity.

Read more

Does your investment portfolio contain only one stock? No. Risk-based contract portfolios should be diversified too.

by Mark Bethke, FSA, MAAA, Managing Director, Deloitte Consulting LLP

Hospitals and health systems will take on gain/loss sharing contracts at different speeds, depending on their own capabilities and the demand in the market. After decades of fee-for-service contracts, it can be difficult and intimidating for a provider organization to move to these arrangements. For many health systems, there will never be a perfect time to start entering into gain/loss sharing contracts.

Read more

When the music changes, so does the dance: Time for biopharma to get in step with value-based contracting

by Joseph M. Coppola, Managing Director, Life Sciences Commercial and Market Access Practice Leader, Deloitte Consulting LLP

There is a well-known African proverb, “When the music changes, so does the dance.” I was thinking about this recently when I was a panelist on SAP’s Changing the Game in Life Sciences radio program, “Outcome-Based Pricing: Cure for An Ailing Healthcare Industry.” The moderator asked me for a quote that I felt best represented what was happening in the industry related to emerging pricing and payment models.

Read more

Beyond dollars and cents: Culture and communications are often keys to success in hospital M&A

by Chad Mulvany, Director, Healthcare Finance Policy, Strategy and Development, Healthcare Financial Management Association and Wendy Gerhardt, Senior Manager, Deloitte Center for Health Solutions, Deloitte Services LP

Hospital and health system executives tend to think about mergers and acquisitions (M&A) in terms of dollars and cents – the value of the deal, transaction dollars, performance, and future projections. But one area that is equally important in hospital M&A transactions – according to new research conducted by the Deloitte Center for Health Solutions and the Healthcare Financial Management Association (HFMA) – is culture and communications.

Read more

Automation in clinical trials? It’s time to take the first step.

by Peter Russell, Principal, Deloitte Consulting LLP and Dawn Anderson, Managing Director, Deloitte Consulting LLP

Life sciences industry, it is time to start talking about robotics and cognitive analytics.

Actually, it’s time to start doing something about it. Many other industries are already there. Publishing, for example, or the automotive industry. Or financial services.

I hear you: “But we’re different. This is R&D in life sciences after all – not publishing.” It’s true – life sciences obviously operates within a web of regulatory oversight and complex science that makes for some unique challenges.

Read more